Skip to main content
TipRanks
Go Ultimate75% OFF

Monopar Therapeutics Inc (MNPR) Q2 2023 Earnings Report

583 Followers

MNPR Q2 2023 EPS Results

Actual EPS
-$0.80
Consensus EPS
-$0.92
Beat/Miss
Beat by +$0.12
One Year Ago EPS
-$1.10

MNPR Q2 2023 Revenue Results

Actual Revenue
$0
Expected Revenue
$0
Beat/Miss
Met expectations
YoY Revenue Growth
―

Earnings Announcement Details

Quarter
Q2 2023
Date
08/10/2023
Time
Before Open
Conference Call
Thursday, August 10, 2023
MNPR Upcoming Earnings

Monopar Therapeutics Inc's next earnings date is estimated for March 25, 2027, based on past reporting schedules.

Q2 2023 Earnings Call Audio

No earnings call audio is available for this earnings event.

Q2 2023 Earnings Slide Deck

No slide deck is available for this earnings event.

Q2 2023 Earnings Call Summary

No earnings call summary is available for this earnings event.

MNPR Earnings History

MNPR earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Mar 25, 20272026 (Q4)―--0.64――
Nov 06, 20262026 (Q3)-0.72-0.72-0.48-50.83% (-0.24)
Aug 12, 20262026 (Q2)-0.65-0.62-0.35-77.14% (-0.27)
May 14, 20262026 (Q1)-0.81-0.46-0.38-21.05% (-0.08)
Mar 27, 20262025 (Q4)-0.48-0.64-2.7476.64% (+2.10)
Nov 13, 20252025 (Q3)-0.42-0.48-0.37-29.73% (-0.11)
Aug 12, 20252025 (Q2)-0.46-0.35-0.530.00% (+0.15)
May 13, 20252025 (Q1)―-1.22-0.5-143.00% (-0.71)
Mar 31, 20252024 (Q4)-0.68-0.38-0.524.00% (+0.12)
Nov 08, 20242024 (Q3)-0.99-0.37-0.747.14% (+0.33)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed